[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ② | Interview with Changjin Lee, CEO of Laseroptek
At IMCAS World 2026 in Paris, France, Changjin Lee, CEO of Laseropteck, shared the company's global strategy. Declaring this year as 'the year of renewed growth,' Lee is accelerating global market expansion with two flagship products—'PicoSculpting' and 'HELIOS 785 PICO'—both built on Laseropteck's proprietary laser technology. With local operations now established in the world's three major aesthetic markets—the US, Europe, and Brazil—and exports reaching over 40 countries, Laseropteck continues to strengthen its global presence. The company also unveiled plans to expand its portfolio with the launch of 'VASCURA 589,' a next-generation vascular treatment laser. Discover the innovation and vision of Laseropteck, a company leading K-Medical Aesthetics.
#MedicalAestheticNews #IMCAS2026 #IMCAS #KMedicalAesthetics #Laseropteck #Sculpio #PicoLoPremium #PicoSculpting #HELIOS785PICO #VASCURA589
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11185

Comments
Post a Comment